Kiox Pharmaceuticals ApS
CVR 42886866 · Private limited company (ApS) · Active · Medium risk
Kiox Pharmaceuticals ApS is a Private limited company (ApS), founded on , based in Snekkersten. The company is registered in the industry andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -404k and a net result of DKK -640k. CEO: Mikkel Walmar, Tim Dehli Carstensen.
Bankruptcy risk for Kiox Pharmaceuticals ApS
1.4 × the average (1.41%) · higher risk than 82% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 42886866
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (4 years)
- Address
- Stolbjergvej 26C
3070 Snekkersten - Municipality
- Helsingør
- Industry
- Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990)
Bankruptcies in the industry: Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. - Share capital
- DKK 311k
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 4 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -35.0% |
| Current ratio | 74% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 120k | DKK -412k |
| Net profit | DKK -640k | DKK -1.8m |
| Equity | DKK -404k | DKK 235k |
| Total assets | DKK 1.2m | DKK 784k |
| Cash | DKK 561k | – |
| Short-term debt | DKK 1.6m | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 181 | ||
| 1 Jan 2024 – 31 Dec 2024 | 176 | ||
| 1 Jan 2023 – 31 Dec 2023 | 180 | ||
| 7 Dec 2021 – 31 Dec 2022 | 174 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Mikkel Walmar | Current | |
| CEO | Tim Dehli Carstensen | Current | |
| Board | Inge Tarnow | Current | |
| Board | Lars Hellerung Christiansen | Current | |
| Board | Mikkel Walmar | Current | |
| Owner (20%) | Titi14 HOLDING ApS | Current | |
| Owner (15%) | HELLERUNG ApS | Current | |
| Owner (50%) | 26c Holding ApS | Current | |
| Owner (100%) | 26c Holding ApS | ||
| Owner (25%) | Titi14 HOLDING ApS | ||
| Owner (67%) | 26c Holding ApS | ||
| Owner (67%) | 26c Holding ApS | ||
| Founder | 26c Holding ApS | Current |
The CEOs' other companies
Mikkel Walmar – 3 other companies
- 26c Holding ApS Active
- Radyx Pharma Tech ApS Active
- Walmar Clinical ApS Active
Tim Dehli Carstensen – 2 other companies
- ClinOption ApS Active
- Titi14 HOLDING ApS Active
Address history (0 moves)
| Stolbjergvej 26C, 3070 Snekkersten |
Other companies at the same address
- 26c Holding ApS Active
- Walmar Clinical ApS Active
Similar companies in Helsingør
- FALKEN INVEST ApS Hornbæk
- Sunde Løsninger ApS Helsingør
- Pixel Platform ApS Hellebæk
- German Tornado ApS Espergærde
- RevX ApS Espergærde
- Flow Rekruttering ApS Helsingør
- ThoboHauth Trading ApS Hornbæk
- Noorbyg ApS Hornbæk
- THINK SMART ApS Espergærde
- P. MØRK ApS Espergærde
- ERIK W HOLDING ApS Helsingør
- M2 CONSULT ApS Hornbæk
Questions and answers about Kiox Pharmaceuticals ApS
Has Kiox Pharmaceuticals ApS gone bankrupt?
No, Kiox Pharmaceuticals ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Kiox Pharmaceuticals ApS?
Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.
Who is the CEO of Kiox Pharmaceuticals ApS?
Mikkel Walmar, Tim Dehli Carstensen are the CEOs of Kiox Pharmaceuticals ApS.
Who is the auditor of Kiox Pharmaceuticals ApS?
Kiox Pharmaceuticals ApS most recently used EY Godkendt Revisionspartnerselskab.
When was Kiox Pharmaceuticals ApS founded?
Kiox Pharmaceuticals ApS was founded on 7 December 2021.
What is the equity of Kiox Pharmaceuticals ApS?
Equity was DKK -404k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.